DIA-MS based plasma peptidomic workflow for profiling organ-derived peptides

preprint OA: closed
Full text JSON View at publisher

Abstract

Plasma contains diverse bioactive peptides that play crucial roles in maintaining homeostasis and regulating disease responses. However, the presence of peptides derived from high-abundance proteins such as albumin makes comprehensive analysis of native peptides secreted by organs challenging. This study aimed to establish a highly sensitive plasma peptidomic approach by combining data-independent acquisition (DIA) with spectral libraries of plasma and organs. First, peptides were extracted from plasma and eleven organ types using a high-yield peptide extraction method, the differential solubilization method. These peptides were then measured via data-dependent acquisition (DDA) analysis using a timsTOF HT for constructing empirical spectral library. Subsequently, DIA-MS data from plasma samples were measured and analyzed using this spectral library. This strategy achieved identification of, on average, over 5,500 peptides per run, with over 2,000 organ-derived peptides including 19 known bioactive peptides. The novel strategy proposed here enables highly sensitive quantitative analysis of organ-derived peptides in plasma, linking them to their secreting organs. It is expected to substantially contribute not only to the discovery of biomarkers and novel bioactive peptides but also to elucidating the pathophysiology of systemic diseases.
Full text 1,445 characters · extracted from oa-doi-fallback · click to expand
Abstract Plasma contains diverse bioactive peptides that play crucial roles in maintaining homeostasis and regulating disease responses. However, the presence of peptides derived from high-abundance proteins such as albumin makes comprehensive analysis of native peptides secreted by organs challenging. This study aimed to establish a highly sensitive plasma peptidomic approach by combining data-independent acquisition (DIA) with spectral libraries of plasma and organs. First, peptides were extracted from plasma and eleven organ types using a high-yield peptide extraction method, the differential solubilization method. These peptides were then measured via data-dependent acquisition (DDA) analysis using a timsTOF HT for constructing empirical spectral library. Subsequently, DIA-MS data from plasma samples were measured and analyzed using this spectral library. This strategy achieved identification of, on average, over 5,500 peptides per run, with over 2,000 organ-derived peptides including 19 known bioactive peptides. The novel strategy proposed here enables highly sensitive quantitative analysis of organ-derived peptides in plasma, linking them to their secreting organs. It is expected to substantially contribute not only to the discovery of biomarkers and novel bioactive peptides but also to elucidating the pathophysiology of systemic diseases. Competing Interest Statement The authors have declared no competing interest.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00